BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 29534854)

  • 1. Within-Host Evolution of Human Influenza Virus.
    Xue KS; Moncla LH; Bedford T; Bloom JD
    Trends Microbiol; 2018 Sep; 26(9):781-793. PubMed ID: 29534854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza B Viruses Exhibit Lower Within-Host Diversity than Influenza A Viruses in Human Hosts.
    Valesano AL; Fitzsimmons WJ; McCrone JT; Petrie JG; Monto AS; Martin ET; Lauring AS
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31801858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic evolution of viruses in host populations.
    Rouzine IM; Rozhnova G
    PLoS Pathog; 2018 Sep; 14(9):e1007291. PubMed ID: 30208108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Relevant Influenza Virus Evolution Reconstituted in a Human Lung Airway-on-a-Chip.
    Si L; Bai H; Oh CY; Jin L; Prantil-Baun R; Ingber DE
    Microbiol Spectr; 2021 Oct; 9(2):e0025721. PubMed ID: 34523991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolution of epidemic influenza.
    Nelson MI; Holmes EC
    Nat Rev Genet; 2007 Mar; 8(3):196-205. PubMed ID: 17262054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of Influenza A Virus by Mutation and Re-Assortment.
    Shao W; Li X; Goraya MU; Wang S; Chen JL
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28783091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Within-Host Viral Diversity: A Window into Viral Evolution.
    Lauring AS
    Annu Rev Virol; 2020 Sep; 7(1):63-81. PubMed ID: 32511081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing of Drugs as Novel Influenza Inhibitors From Clinical Gene Expression Infection Signatures.
    Pizzorno A; Terrier O; Nicolas de Lamballerie C; Julien T; Padey B; Traversier A; Roche M; Hamelin ME; Rhéaume C; Croze S; Escuret V; Poissy J; Lina B; Legras-Lachuer C; Textoris J; Boivin G; Rosa-Calatrava M
    Front Immunol; 2019; 10():60. PubMed ID: 30761132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Sequencing: An Eye-Opener for the Surveillance of Antiviral Resistance in Influenza.
    Van Poelvoorde LAE; Saelens X; Thomas I; Roosens NH
    Trends Biotechnol; 2020 Apr; 38(4):360-367. PubMed ID: 31810633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza genome diversity and evolution.
    Tsai KN; Chen GW
    Microbes Infect; 2011 May; 13(5):479-88. PubMed ID: 21276870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Host immunity and pathogen diversity: A computational study.
    Aquino T; Nunes A
    Virulence; 2016; 7(2):121-8. PubMed ID: 26836775
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamically correlated mutations drive human Influenza A evolution.
    Tria F; Pompei S; Loreto V
    Sci Rep; 2013; 3():2705. PubMed ID: 24048220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host species barriers to influenza virus infections.
    Kuiken T; Holmes EC; McCauley J; Rimmelzwaan GF; Williams CS; Grenfell BT
    Science; 2006 Apr; 312(5772):394-7. PubMed ID: 16627737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the complex evolution of rapidly mutating viruses with deep sequencing: Beyond the analysis of viral diversity.
    Leung P; Eltahla AA; Lloyd AR; Bull RA; Luciani F
    Virus Res; 2017 Jul; 239():43-54. PubMed ID: 27888126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deep Sequencing of Influenza A Virus from a Human Challenge Study Reveals a Selective Bottleneck and Only Limited Intrahost Genetic Diversification.
    Sobel Leonard A; McClain MT; Smith GJ; Wentworth DE; Halpin RA; Lin X; Ransier A; Stockwell TB; Das SR; Gilbert AS; Lambkin-Williams R; Ginsburg GS; Woods CW; Koelle K
    J Virol; 2016 Dec; 90(24):11247-11258. PubMed ID: 27707932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influenza Evolution: New Insights into an Old Foe.
    Moncla LH; Florek KR; Friedrich TC
    Trends Microbiol; 2017 Jun; 25(6):432-434. PubMed ID: 28478941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution, safety, and highly pathogenic influenza viruses.
    Lipsitch M; Plotkin JB; Simonsen L; Bloom B
    Science; 2012 Jun; 336(6088):1529-31. PubMed ID: 22723411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple Sources of Genetic Diversity of Influenza A Viruses during the Hajj.
    Cobbin JCA; Alfelali M; Barasheed O; Taylor J; Dwyer DE; Kok J; Booy R; Holmes EC; Rashid H
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of selective resistance of influenza A virus in presence of host-targeted antiviral, UV-4B.
    Warfield KL; Schaaf KR; DeWald LE; Spurgers KB; Wang W; Stavale E; Mendenhall M; Shilts MH; Stockwell TB; Barnard DL; Ramstedt U; Das SR
    Sci Rep; 2019 May; 9(1):7484. PubMed ID: 31097731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Influenza A Virus Sequence Pairs and Their Combinations for Simultaneous Heterosubtypic Targeting that Hedge against Antiviral Resistance.
    Wee KB; Lee RT; Lin J; Pramono ZA; Maurer-Stroh S
    PLoS Comput Biol; 2016 Jan; 12(1):e1004663. PubMed ID: 26771381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.